Skip to main content

Spruce Biosciences, Inc.

SPRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001683553

No open-market purchases or sales by Spruce Biosciences, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $116.3M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Spruce Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of SPRB: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders5038−12
Shares18.0M16.6M−1.38M (−7.7%)
Value$14.1M$8.61M−$5.51M (−39.0%)

New holders (5)

Institutions that held Spruce Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SPRB in Q2 2024
InstitutionSharesValue% of portfolio
Almitas Capital LLC396,506$205.3K0.09%
683 Capital Management, LLC140,934$73.0K0.01%
Marex Group plc14,800$7.66K0.00%
Shay Capital LLC13,172$6.82K0.00%
Royal Bank of Canada216$00.00%

Sold out (17)

Institutions that held Spruce Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of SPRB in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Aisling Capital Management LP1,205,511$947.5K
Panagora Asset Management Inc253,682$199.4K
AWM Investment Company, Inc.200,000$157.2K
Walleye Capital LLC178,958$140.6K
Millennium Management LLC102,223$80.3K
Marshall Wace, LLP72,245$57.1K
Castleview Partners, LLC59,709$46.9K
Dimensional Fund Advisors LP46,664$36.7K
Susquehanna International Group, LLP29,709$23.3K
Simplex Trading, LLC28,100$22.0K
Two Sigma Securities, LLC26,016$20.4K
Belvedere Trading LLC24,900$19.6K
Balyasny Asset Management LLC22,508$17.7K
Omers Administration Corp16,000$12.6K
Wells Fargo & Company143$112
FMR LLC103$81
Macquarie Group Ltd362$0